Risk factors for developing mineral bone disease in phenylketonuric patients.

@article{Mirs2013RiskFF,
  title={Risk factors for developing mineral bone disease in phenylketonuric patients.},
  author={Alicia Mir{\'a}s and Ma Dolores B{\'o}veda and Mar{\'i}a R Leis and Antonio Chamorro Mera and Luis Aldamiz-Echevarr{\'i}a and Jos{\'e} Ram{\'o}n Fern{\'a}ndez-Lorenzo and Jos{\'e} M. Fraga and Mar{\'i}a L Couce},
  journal={Molecular genetics and metabolism},
  year={2013},
  volume={108 3},
  pages={149-54}
}
There is a compromised bone mass in phenylketonuria patients compared with normal population, but the mechanisms responsible are still a matter of investigation. In addition, tetrahydrobiopterin therapy is a new option for a significant proportion of these patients and the prevalence of mineral bone disease (MBD) in these patients is unknown. We conducted a cross-sectional observational study including 43 phenylketonuric patients. Bone densitometry, nutritional assessment, physical activity… CONTINUE READING
10 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…